News
RIGL
18.86
-0.95%
-0.18
Rigel Pharmaceuticals Announces New Inducement Grants for Non-Executive Employees Under NASDAQ Rule 5635(c)(4)
Reuters · 3d ago
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
PR Newswire · 3d ago
Weekly Report: what happened at RIGL last week (0630-0704)?
Weekly Report · 3d ago
Weekly Report: what happened at RIGL last week (0623-0627)?
Weekly Report · 06/30 09:03
Weekly Report: what happened at RIGL last week (0616-0620)?
Weekly Report · 06/23 09:03
Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year
Simply Wall St · 06/18 10:08
Weekly Report: what happened at RIGL last week (0609-0613)?
Weekly Report · 06/16 09:03
Nuvation Bio: Judgement Day Grows Closer
Seeking Alpha · 06/10 19:19
Weekly Report: what happened at RIGL last week (0602-0606)?
Weekly Report · 06/09 09:03
Promising Efficacy and Market Potential for GAVRETO in RET Fusion-Positive Tumors
TipRanks · 06/03 10:27
Weekly Report: what happened at RIGL last week (0526-0530)?
Weekly Report · 06/02 09:04
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
NASDAQ · 05/29 13:40
Weekly Report: what happened at RIGL last week (0519-0523)?
Weekly Report · 05/26 09:04
Rigel Pharmaceuticals Approves Equity Plan Amendment
TipRanks · 05/23 20:49
Rigel Pharmaceuticals To Present Final GAVRETO Phase 1/2 ARROW Study Data In RET Fusion-Positive NSCLC And Solid Tumors, Along With Supportive REZLIDHIA Data For mIDH1 R/R AML At ASCO And EHA 2025 Conferences
Benzinga · 05/22 21:36
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress
PR Newswire · 05/22 21:20
Weekly Report: what happened at RIGL last week (0512-0516)?
Weekly Report · 05/19 09:03
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why
Simply Wall St · 05/15 11:23
Weekly Report: what happened at RIGL last week (0505-0509)?
Weekly Report · 05/12 09:03
Biotech Alert: Searches spiking for these stocks today
TipRanks · 05/09 15:55
More
Webull provides a variety of real-time RIGL stock news. You can receive the latest news about Rigel Pharmaceuticals Inc through multiple platforms. This information may help you make smarter investment decisions.
About RIGL
Rigel Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. It is focused on products that address signaling pathways that are critical to disease mechanisms. Its first product is TAVALISSE (fostamatinib disodium hexahydrate) tablets, the approved oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Its second product is REZLIDHIA (olutasidenib) capsules for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. Its GAVRETO (pralsetinib) product is a once daily, small molecule, oral, kinase inhibitor of wild type rearranged during transfection (RET) and oncogenic RET fusions.